January 23, 2023

EDITORIAL ARTICLE: The future of drug development for complex pathologies: Versatile cell-based assays and customizable cell lines

In this Editorial Article, Dr. Michael Tovey, Chief Scientific Advisor & inventor of the iLite® technology at Svar Life Science, highlights how cell-based assays are helping the development of complex biotherapeutics.

 

The article also presents how this advanced engineering platform works and how it enables the design and construction of complex and sophisticated components. The possibilities are endless when it comes to the potential number of target combinations.

January 23, 2023

EDITORIAL ARTICLE: The future of drug development for complex pathologies: Versatile cell-based assays and customizable cell lines

In this Editorial Article, Dr. Michael Tovey, Chief Scientific Advisor & inventor of the iLite® technology at Svar Life Science, highlights how cell-based assays are helping the development of complex biotherapeutics.

 

The article also presents how this advanced engineering platform works and how it enables the design and construction of complex and sophisticated components. The possibilities are endless when it comes to the potential number of target combinations.

iLite® A VERSATILE TOOL FOR DRUG DEVELOPMENT 
Providing a seamless solution for applications extending across the whole process

Numerous pharmaceutical and biotechnology companies have benefited from the development of iLite custom reporter gene assays.

With the development of increasingly complex biotherapeutics for the treatment of diseases with complex pathologies, iLite cell-based Assays are uniquely positioned to meet the challenges this pose.


Complete the form to access the editorial article!